Bill Sponsor
House Bill 2149
117th Congress(2021-2022)
Protecting Americans with Pre-existing Conditions Act of 2021
Introduced
Introduced
Introduced in House on Mar 23, 2021
Overview
Text
Introduced in House 
Mar 23, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Mar 23, 2021)
Mar 23, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 2149 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 2149


To provide that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.


IN THE HOUSE OF REPRESENTATIVES

March 23, 2021

Ms. Kuster (for herself, Mr. Beyer, and Mr. Courtney) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To provide that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Americans with Pre-existing Conditions Act of 2021”.

SEC. 2. Providing that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect.

(a) In general.—The Secretary of Health and Human Services and the Secretary of the Treasury may not take any action to implement, enforce, or otherwise give effect to the rules and guidance described in subsection (b), and no such rules and guidance shall have any force or effect.

(b) Rules and guidance.—The rules and guidance described in this subsection are the following:

(1) The provisions in the final rule issued by the Secretary of Health and Human Services and the Secretary of the Treasury on January 19, 2021, relating to “Updates to State Innovation Waiver (Section 1332 Waiver) Implementing Regulations” (86 Fed. Reg. 6138).

(2) The guidance issued by such Secretaries entitled “State Relief and Empowerment Waivers” (83 Fed. Reg. 53575 (October 24, 2018)), or any other rule promulgated to give effect to such guidance.